Abstract
Type A viral hepatitis, or “infectious” hepatitis, is almost certainly an ancient disease, with descriptions of contagious jaundice described as long ago as the fifth century B.C. (reviewed in ref. 188). Although infectious causes of hepatitis other than hepatitis A virus (HAV) may have been responsible for some of these outbreaks, the description of many outbreaks of epidemic jaundice appear to have resulted from HAV infection. Recognition of infectious hepatitis as a distinct clinical entity did not begin to evolve until the first part of the twentieth century (106,188). Infectious hepatitis was a major problem for military forces during World War II, prompting studies that demonstrated the existence of at least two distinct transmissible hepatitis agents, one responsible for short-incubation, “infectious” jaundice (subsequently renamed type A hepatitis) and the other causing long-incubation, “homologous serum” jaundice (type B hepatitis) (62,98,99,113,114). These two agents were distinguished by differences in incubation periods, apparent modes of transmission, and lack of cross-protection in human challenge studies (113). Several decades later, with the advent of specific tests for hepatitis A and B viruses, it became apparent that most cases of post-transfusion hepatitis could be attributed to neither of these viruses (2). This led to the realization that there were other distinct types of viral hepatitis, termed “non-A, non-B” hepatitis. The most common etiologic agent of this entity was identified in 1989, and it has since been named hepatitis C (16).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aach, R. D., Szmuness, W., Mosely, J. W., Hollinger, F. B., Kahn, R. A., Stevens, C. E., and Edwards, V. M. (1981) Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the transfusion-transmitted viruses study. N. Engl. J. Med. 304, 989–994.
Alter, H. J., Purcell, R. H., Feinstone, S. M., Holland, P. V., and Morrow, A. G. (1978) Non-A, non-B hepatitis: a review and interim report of an ongoing study, in Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis, and Prevention ( Vyas, G. N., Cohen, S. H., and Schmid, R., eds.), Franklin Inst. Press, Philadelphia, PA, pp. 359–369.
Anderson, D. A. (1987) Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM-175. J. Med. Virol. 22, 35–44.
Anderson, D. A. and Ross, B. C. (1990) Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J. Virol. 64, 5284–5289.
Arnold, E., Luo, M., Vriend, G., Rossmann, M. G., Palmenberg, A. C., Parks, G. D., Nicklin, M. J. H., and Wimmer, E. (1987) Implications of the picornavirus capsid structure for polyprotein processing. Proc. Natl. Acad. Sci. USA 84, 21–25.
Bergmann, E. M., Mosmann, S.C., Chernaia, M. M., Malcolm, B. A., and James, M. N. (1997) The refined crystal structure of the 3C gene product from hepatitis A virus: specific proteinase activity and RNA recognition. J. Virol. 71, 2436–2448.
Binn, L. N., Bancroft, W. H., Lemon, S. M., Marchwicki, R. H., LeDuc, J. W., Trahan, C. J., Staley, E. C., and Keenan, C. M. (1986) Preparation of a prototype hepatitis A virus vaccine from infected cell culture. J. Infect. Dis. 153, 749–756.
Bishop, N. E. and Anderson, D. A. (1991) Morphogenesis of Hepatitis A virus. Europic 91. Seventh Meeting European Study Group Picornavirus, G10.
Borovec, S. V. and Anderson, D. A. (1993) Synthesis and assembly of hepatitis A virus-specific proteins in BS-C-1 cells. J. Virol. 67, 3095–3102.
Bromberg, K., Newhall, D. N., and Peter, G. (1982) Hepatitis A and meningoencephalitis. JAMA 247, 815.
Cederna, J. B. and Stapleton, J. T. (1994) Hepatitis A, in Manual of Clinical Microbiology (Yolken, R. H., ed.), Am. Soc. Microbiol. Washington.
Centers for Disease Control (1988) Hepatitis A among drug abusers. MMWR 37, 297–305.
Chio, F., Jr. and Bakir, A. A. (1992) Acute renal failure in hepatitis A. Int. J. Artif. Organs 15, 413–416.
Chiriaco, P., Guadalupi, C., Armigliato, M., Bortolotti, F., and Realdi, G. (1986) Polyphasic course of hepatitis type A in children. J. Infect. Dis. 153, 378–379.
Cho, M. W. and Ehrenfeld, E. (1991) Rapid completion of the replication cycle of Hepatitis A virus subsequent to reversal of guanidine inhibition. Virology 180,770–780.
Choo, Q. L., Kuo, G., Weiner, A., Overby, L., Bradley, D. W., and Houghton, M. (1989) Isolation of a cDNA derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359–362.
Cobden, I. and James, O. F. W. (1986) A biphasic illness associated with acute hepatitis A virus infection. J. Hepatol. 2, 19–23.
Cohen, J. I., Feinstone, S., and Purcell, R. H. (1989) Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J. Infect. Dis. 160, 887–890.
Cohen, J. I., Rosenblum, B., Ticehurst, J. R., Daemer, R. J., Feinstone, S., and Purcell, R. H. (1987) Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc. Natl. Acad. Sci. USA 84, 2497–2501.
Cohen, J. I., Rosenblum, R., Daemer, R. J., Ticehurst, J. R., Feinstone, S. M., and Purcell, R. H. (1988) Attenuation of hepatitis A virus: molecular analysis, in Viral Hepatitis and Liver Disease (Zuckerman, A. J., ed.), Alan R. Liss, New York, pp. 43–47.
Cohen, J. I., Ticehurst, J. R., Feinstone, S. M., Rosenblum, B., and Purcell, R. H. (1987) Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J. Virol. 61, 3035–3039.
Cohen, J. I., Ticehurst, J. R., Purcell, R. H., Buckler-White, A., and Baroudy, B. M. (1987) Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picomaviruses. J. Viral. 61, 50–59.
Corey, L. and Holmes, K. K. (1980) Sexual transmission of hepatitis A in homosexual men. N. Engl. J. Med. 302, 435–446.
Cornu, C., Lamy, M. E., Geubel, A., and Galanti, L. (1984) Persistence of immunoglobulin M antibody to hepatitis A virus and relapse of hepatitis A infection. Eur. J. Clin. Microbiol. 3, 45–46.
Coulepis, A. G., Locarnini, S. A., Westaway, E. G., Tannock, G. A., and Gust, I. D. (1982) Biophysical and biochemical characterization of hepatitis A virus. Intervirology 18, 107–127.
Cromeans, T., Sobsey, M. D., and Fields, H. A. (1987) Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus. J. Med. Virol. 22, 45–56.
Daemer, R. J., Feinstone, S. M., Gust, I. D., and Purcell, R. H. (1981) Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect. Immun. 32, 388–393.
Day, S. P., Murphy, P., Brown, E. A., and Lemon, S. M. (1992) Mutations within the 5’ nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells. J. Virol. 66, 6533–6540.
Dinakarpandian, D., Shenoy, B., Pusztai-Carey, M., Malcolm, B. A., and Carey, P. R. (1997) Active site properties of the 3C proteinase from hepatitis A virus (a hybrid cysteine/serine protease) probed by Raman spectroscopy. Biochemistry 36, 49434948.
Doebbeling, B. N., Li, N., and Wenzel, R. P. (1993) An outbreak of hepatitis A among health care workers: risk factors for transmission. Amer. J. Public Health 83, 1679–1684.
Dollberg, S., Berkun, Y., and Gross-Kieselstein, E. (1991) Urticaria in patients with hepatitis A virus infection. Pediatr. Infect. Dis. J. 10, 702–703.
Dotzauer, A., Feinstone, S. M., and Kaplan, G. (1994) Susceptibility of nonprimate cell lines to HAV infection. J. Virol. 68, 6064–6068.
Dotzauer, A., Vallbracht, A., and Keil, G. M. (1995) The proposed gene for VP1 of hepatitis A virus encodes for a larger protein than that observed in HAY-infected cells and virions. Virology 213, 671–675.
Edgar, W. M. and Campbell, A. D. (1985) Nosocomial infection with hepatitis A. J. Infect. 10, 43–47.
Ellerbeck, E., Lewis, J., Midthun, K., Gershman, K., Nalin, D., McCaughtry, H. Provost, P., and Caladra, G. (1990) Safety and immunogenicity of an inactivated hepatitis A virus vaccine, 1990 Intern. Symposium Viral Hepatitis Liver Dis. Abstr. 43, 50.
Emerson, S. U., Huang, Y. K., and Purcell, R. H. (1993) 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. Virology 194, 475–480.
Emerson, S. U., Huang, Y. K., McRill, C., Lewis, M., Shapiro, M., London, W. T., and Purcell, R. H. (1992) Molecular basis of virulence and growth of hepatitis A virus in cell culture. Vaccine 10 (Suppl. 1), S36–839.
Enriquez, R., Frösner, G. G., Hochstein-Mintzel, V., Riedemann, S., and Reinhardt, G. (1992) Accumulation and persistence of hepatitis A virus in mussels. J. Med. Virol. 37, 174–179.
Feinstone, S. M., Kapikian, A. Z., and Purcell, R. H. (1973) Hepatitis A: detection by immune electron microscopy of a virus like antigen associated with acute illness. Science 182, 1026–1028.
Flehmig, B. (1981) Hepatitis A virus in cell culture. II. Growth characteristics of hepatitis A virus in Frhk-4/R cells. Med. Microbiol. Immunol. 170, 73–81.
Flehmig, B., Heinricy, U., and Pfisterer, M. (1989) Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers. Lancet 1, 1039–1041.
Flehmig, B., Ranke, M., Berthold, T., and Gerth, H. J. (1979) A solid phase radio-immunoassay for detection of IgM antibodies to hepatitis A virus. J. Infect. Dis. 140, 169–175.
Fleischer, B., Fleischer, S., Maier, K., Wiedmann, K. H., and Vallbracht, A. (1990) Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology 69, 14–19.
Francis, D. P., Hadler, S. C., Prendergast, T. J., Peterson, E., Ginsberg, M. M., Lookabaugh, C., Holmes, J. R., and Maynard, J. E. (1984) Occurrence of hepatitis A, B., and non-A/non-B in the United States. CDC Sentinel County Hepatitis Study 1. Amer. J. Med. 76, 69–74.
Friedman, L. S. and Dienstag, J. L. (1984) The disease and its pathogenesis, in Hepatitis A (Gerety, R. J., ed.), Academic, London, pp. 55–79.
Frosner, G. G., Overby, L. R., Flehmig, B., Gerth, H. J., Haase, H., Decker, R. H., Ling, C. M., Zuckerman, A. J., and Frosner, H. R. (1977) Seroepidemiological investigation of patients and family contacts in an epidemic of hepatitis A. J. Med. Virol. 1, 163–173.
Gabriel, P., Vallbracht, A., and Flehmig, B. (1986) Lack of complement-dependent cytolytic antibodies in hepatitis A virus infection. J. Med. Virol. 20, 23–31.
Gauss-Muller, V., Zhou, M. Q., von der Helm, K., and Deinhardt, F. (1990) Recombinant proteins VP 1 and VP3 of hepatitis A virus prime for neutralizing response. J. Med. Virol. 31, 277–283.
Gerety, R. J. (1984) Hepatitis A. Academic, London.
Glikson, M., Galun, E., Oren, R., Tur-Kaspa, R., and Shouval, D. (1992) Relapsing hepatitis A. Review of 14 cases and literature survey. Medicine (Baltimore) 71, 1423.
Gordon, S. C., Patel, A. S., Veneri, R. J., Keskey, K. A., and Korotkin, S. M. (1989) Case report: acute type a hepatitis presenting with hypotension, bradycardia, and sinus arrest. J. Med. Virol. 28, 219–222.
Gordon, S. C., Reddy, K. R., Schiff, L., and Schiff, E. R. (1984) Prolonged intrahepatic cholestasis secondary to acute hepatitis A. Ann. Int. Med. 101, 635–637.
Gosert, R., Cassinotti, P., Siegl, G., and Weitz, M. (1996) Identificationn of hepatitis A virus non-structural protein 2B and its release by the major virus protease 3C. J. Gen. Viral. 77, 247–255.
Graff, J., Normann, A., Feinstone, S. M., and Flehmig, B. (1994) Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants. J. V irol. 68, 548–554.
Gundersen, S. G., Bjoerneklett, A., and Bruun, J. N. (1989) Severe erythroblastopenia and hemolytic anemia during a hepatitis A infection. Scand. J. Infect. Dis. 21, 225–228.
Gust, I. D., Coulepis, A. G., Feinstone, S. M., Locarnini, S.A., Moritsugu, Y., Najera, R., and Siegl, G. (1983) Taxonomic classification of hepatitis A virus. Intervirology 20, 1–7.
Gust, I. D. and Feinstone, S. M. (1988) Hepatitis A. CRC Boca Raton, Florida.
Gust, I. D., Lehmann, N. I., and Lucas, C. R. (1978) Studies on the epidemiology of hepatitis A in Melbourne, in Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis, and Prevention ( Vyas, G. N., Cohen, S. H., and Schmid, R., eds.), Franklin Inst. Press, Philadelphia, PA, pp. 105–112.
Hadler, S. C. (1991) Viral Hepatitis and Liver Disease. Williams & Wilkins, Baltimore, MD, pp. 14–20.
Radler, S. C. and McFarland, L. (1986) Hepatitis in day care centers: epidemiology and prevention. Rev. Infect. Dis. 8, 548–557.
Hadler, S.C., Webster, H. M., Erben, J. J., Swanson, J. E., and Maynard, J. E. (1980) Hepatitis A in day-care centers. A community-wide assessment. N. Engl. J. Med. 302, 1222–1227.
Hall, W. T., Bradley, D. W., Madden, D L, Zimmerman, D. H., and Brandt, D. E. L. (1977) Comparison of sensitivity of radioimmunoassay and immune electron microscopy for detecting hepatitis A antigen in fecal extracts. Proc. Soc. Exp. Biol. Med. 155, 193–198.
Halliday, M. L., Kang, L. Y., Zhou, T. K., Hu, M. D., Pan, Q. C., Fu, T. Y., Huang, Y. S., and Hu, S. L. (1991) An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J. Infect. Dis. 164, 852–859.
Hamman, J., Zou, J., and Horowitz, B. (1994) Removal and inactivation of hepatitis A virus (HAV) during processing of factor VIII concentrates. Vox Sanguinis 67, sl, 72–77.
Harber, J. J., Bradley, J., Anderson, C. W., and Wimmer, E. (1991) Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2. J. Virol. 65, 326–334.
Harmon, S. A., Emerson, S. U., Huang, Y. K., Summers, D. F., and Ehrenfeld, E. (1995) Hepatitis A viruses with deletions in the 2A gene are infectious in cultured cells and marmosets. J. Viral. 69, 5576–5581.
Harmon, S. A., Updike, W., Jia, X.-Y., Summers, D. F., and Ehrenfeld, E. (1992) Polyprotein Processing in cis and trans by hepatitis A virus 3C protease cloned and expressed in escherichia coli. J. Viral. 66, 5242–5247.
Hollinger, F. B. and Glombicki, A. R. (1990) Hepatitis A virus, in Principles and Practices of Infectious Diseases ( Mandell, G. L., Douglas, R. G., Jr., and Bennett, J. E., eds.), Churchill Livingstone, New York, pp. 1383–1399.
Hollinger, F. B. and Ticehurst, J. (1990) Hepatitis A virus, in Virology ( Fields, B. N. and Knipe, D. M., eds.), Raven, New York, pp. 631–667.
Holter, E. and Siebke, J. (1988) Hepatitis A in young Norwegian drug addicts and prison inmates. Infection 16, 91–94.
Inman, R. D., Hodge, M., Johnston, M. E. A., Wright, J., and Heathcote, J. (1986) Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann. Int. Med. 105, 700–703.
Innis, B. L., Snitbhan, R., and Hoke, C. H. (1991) The declining transmission of hepatitis A in Thailand. J. Infect. Dis. 163, 989–995.
Jacobson, I. M., Nath, B. J., and Dienstag, J. L. (1985) Relapsing viral hepatitis type A. J. Med. Virol. 16, 163–169.
Jansen, R. W., Newbold, J. E., and Lemon, S. M. (1985) Combined immunoaffinity cDNA-RNA hybridization assay for detection of hepatitis A virus in clinical specimens. J. Clin. Microbiol. 22, 984–989.
Jansen, R. W., Newbold, J. E., and Lemon, S. M. (1988) Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology 163, 299–307.
Jansen, R. W., Siegl, G., and Lemon, S. M. (1990) Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method. Proc. Natl. Acad. Sci. USA 87, 2867–2871.
Jewell, D. A., Swietnicki, W., Dunn, B. M., and Malcolm, B. A. (1992) Hepatitis A virus 3C proteinase substrate specificity. Biochemistry 31, 7862–7869.
Johnston, J. M., Harmon, S. A., Binn, L. N., Richards, O. C., Ehrenfeld, E., and Summers, D. F. (1988) Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli. J. Infect. Dis. 157, 1203–1211.
Joseph, R. R., Millar, J. D., and Henderson, D. A. (1965) An outbreak of hepatitis traced to food contamination. N. Engl. J. Med. 273, 188–194.
Kallinowski, B., Gmelin, K., Kommerell, B., Bock, H. L., Clemens, R., Scheiermann, N., Wohland, B., Hofmann, E, and Theilmann, L. (1992) Immunogenicity, reactogenicity and consistency of a new, inactivated hepatitis A vaccine-a randomized multicentre study with three consecutive vaccine lots. Vaccine 10, 500–501.
Kaplan, G., Totsuka, A., Thompson, P., Akatsuka, T., Moritsugu, Y., and Feinstone, S. M. (1996) Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. EMBO J. 15, 4286–4296.
Karayiannis, R, O’Rourke, S., Waters, J., Watts, R., and Thomas, H. C. (1994) Studies of cytotoxic T lymphocyte activity in Tamarins with acute hepatitis A virus infection, in Viral Hepatitis and Liver Disease ( Nishioka, K., Suzuki, H., Mishiro, S., and Oda, T., eds.), Springer-Verlag, Tokyo, pp. 155–157.
Karron, R. A., Daemer, R. J., Ticehurst, J. R., D’Hondt, E., Popper, H., Mihalik, K., Philips, J., Feinstone, S., and Purcell, R. H. (1988) Studies of prototype live hepatitis A virus vaccine in primate models. J. Infect. Dis. 157, 338–345.
Katz, M. H., Hsu, L., Wong, E., Liska, S., and Anderson, L. (1997) Seroprevalence of and risk factors for hepatitis A infection among young homosexual and bisexual men. J. Infect. Dis. 175, 1225–1229.
Krausslich, H.-G. and Wimmer, E. (1988) Viral proteinases. Ann. Rev. Biochem. 57, 701–754.
Kurane, I., Binn, L. N., Bancroft, W. H., and Ennis, F. A. (1985) Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells. J. Immunol. 135, 2140–2144.
LeDuc, J. W., Lemon, S. M., Keenan, C. M., Graham, R. R., Marchwicki, R. H., and Binn, L. N. (1983) Experimental infection of the new world owl monkey (Aotus trivirgatus) with hepatitis A virus. Infect. Immun. 40, 766–772.
Lemon, S. M. (1985) Type A viral hepatitis. New developments in an old disease. N. Engl. J. Med. 313, 1059–1067.
Lemon, S. M. (1995) Hepatitis A virus and blood products: virus validation studies. Blood Coagulation and Fibrinolysis 6, s20 - s22.
Lemon, S. M. and Binn, L. N. (1983) Antigenic relatedness of two strains of hepatitis A virus determined by cross-neutralization. Infect. Immun. 42, 418–420.
Lemon, S. M., Binn, L. N., Marchwicki, R., Murphy, P. C., Ping, L. H., Jansen, R. W., Asher, L. V. S., Stapleton, J. T., Taylor, D. W., and LeDuc, J. W. (1990), in vivo replication and reversion to a wild type of a neutralization-resistant antigenic variant of hepatitis A virus. J. Infect. Dis. 161, 7–13.
Lemon, S. M., Binn, L. N., and Marchwicki, R. H. (1983) Radioimmunofocus assay for quantitation of hepatitis A virus in cell culture. J. Clin. Microbiol. 17, 834–839.
Lemon, S. M., Chao, S.F., Jansen, R. W., Binn, L. N., and LeDuc, J. W. (1987) Genomic heterogeneity among human and nonhuman strains of hepatitis A virus. J. Virol. 61, 735–742.
Lemon, S. M., Jansen, R. W., and Newbold, J. E. (1985) Infectious hepatitis A particles produced in cell culture consist of three distinct types with different buoyant densities in CsC1. J. Virol. 54, 78–85.
Lemon, S. M. and Stapleton, J. T. (1994) Prevention of hepatitis A, in Viral Hepatitis ( Zuckerman, A. J. and Thomas, H. C., eds.), Churchill Livingstone, London, pp. 61–79.
Lorenz, D., Barker, L., and Stevens, D. (1970) Hepatitis in the marmoset: saguinus mystax. Proc. Soc. Exp. Biol. Med. 135, 348–354.
Ludmerer, K. M. and Kissane, J. M. (1984) Fulminant hepatic failure in a 21-year old man. Amer. J. Med. 76, 718–724.
MacCallum, F. O. (1947) Homologous serum jaundice. Lancet 2, 691–692.
MacCallum, F. O. and Bradley, W. H. (1944) Transmission of infective hepatitis to human volunteers. Lancet 2, 228.
Malcolm, B. A., Chin, S. M., Jewell, D. A., Stratton-Thomas, J. R., Thudium, K. B., Ralston, R., and Rosenberg, S. (1992) Expression and characterization of recombinant hepatitis A virus 3C proteinase. Biochemistry 31, 3358–3363.
Mao, J. (1990) Development of live, attenuated hepatitis A vaccine (H2-strain). Vaccine 8, 523–524.
Martin, A., Escriou, N., Chao, S.-F., Girard, M., Lemon, S. M., and Wychowski, C. (1995) Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts. Virology 213, 213–222.
Mathiesen, L. R., Feinstone, S. M., Wong, D. C., Skinhoej, P., and Purcell, R. H. (1978) Enzyme-linked immunosorbent assay for detection of hepatitis A antigen in stool and antibody to hepatitis A antigen in sera: comparison with solid-phase radio-immunoassay, immune electron microscopy, and immune adherence hemagglutination assay. J. Clin. Microbiol. 7, 184–193.
Maynard, J. E. (1963) Infectious hepatitis at Fort Yukon, Alaska-report of an outbreak, 1960–1961. Amer. J. Public Health 53, 31–39.
McCaustland, K. A., Bond, W. W., Bradley, D. W., Ebert, J. W., and Maynard, J. E. (1982) Survival of hepatitis A virus in feces after drying and storage for one month. J. Clin. Microbiol. 16, 957–958.
McDonald, S. (1908) Acute yellow atrophy of the liver. Edinburgh Med. J. 15, 208.
McLinden, J.,Stapleton, J., and Rosen, E. (1991) Anti-HAY neutralizing antibodies made to antigens produced by recombinant baculoviruses, in Vaccines 91: Modern Approaches to New Vaccines (Ginsberg, H., Brown, F., Lerner, R. A., and Chanock, R., eds.), Cold Spring Harbor, New York, pp. 239–244.
Melnick, J. L. (1982) Classification of hepatitis A virus as enterovirus type 72 and of hepatitis B virus as hepadnavirus type 1. Intervirology 18, 105–106.
Mijch, A. M. and Gust, I. D. (1986) Clinical, serologic and epidemiologic aspects of hepatitis A virus infection. Semin. Liver Dis. 6, 42–45.
Miller, M. J. (1993) Summary of current nomenclature, taxonomy, and classification of various microbial agents. Clin. Infect. Dis. 16, 597–615.
Murphy, P., Ping, L. H., and Lemon, S. M. (1993) Peptide scanning demonstrates the presence of a linear epitope located near the carboxy terminus of VP1 of hepatitis A virus. 8th Intern. Symp. Viral Hepatitis Liver Disease, 102.
Najarian, R., Caput, D., and Gee, W. (1985) Primary structure and gene organization of human hepatitis A virus. Proc. Natl. Acad. Sci. USA 82, 2627–2631.
Neefe, J. R., Stokes, J., and Gellis, S. S. (1945) Homologous serum hepatitis and infectious (epidemic) hepatitis: experimental study of immunity and cross immunity in volunteers. Amer. J Med. Sci. 210, 561–575.
Neefe, J. R. and Stokes, J., Jr. (1945) An epidemic of infectious hepatitis apparently due to a water borne agent. JAMA 128, 1063.
Niu, M. T., Polish, L. B., Robertson, B. H., Khanna, B. K., Woodruff, B. A., Shapiro, C. N., Miller, M. A., Smith, J. D., Gedrose, J. K., Alter, M. J., and Margolis, H. S. (1992) Multistate outbreak of hepatitis A associated with frozen strawberries. J. Infect. Dis. 166, 518–524.
Norkrans, G. (1978) Clinical, epidemiological and prognostic aspects of hepatitis A, B and “non-A, non-B.” Scand. J. Infect. Dis. 17, sl-s44.
Normann, A., Graff, J., Gerritzen, A., Brackmann, H.-H., and Flehmig, B. (1992) Detection of hepatitis A virus RNA in commercially available factor VIII preparation. Lancet 340, 1232–1233.
Ostermayr, R., von der Helm, K., Gauss-Muller, V., Winnacker, E. L., and Deinhardt, F. (1987) Expression of hepatitis A virus cDNA in Escherichia coli: antigenic VP1 recombinant protein. J. Viral. 61, 3645–3647.
Palmenberg, A. C. (1990) Proteolytic processing of picornaviral polyprotein. Ann. Rev. Microbiol. 44, 603–623.
Parry, J. V. and Mortimer, P. P. (1984) The heat sensitivity of hepatitis A virus determined by a simple tissue culture method. J. Med. Vrol. 14, 277–283.
Peterson, D. A., Hurley, T. R., and Hoff, J. C. (1983) Effect of chlorine treatment on infectivity of hepatitis A virus. Appl. Environ. Microbiol. 45, 223–227.
Pickering, L. K. (1987) Infections in day care. Ped. Infect. Dis. 6, 614–617.
Ping, L.-H., Jansen, R. W., Stapleton, J. T., Cohen, J. I., and Lemon, S. M. (1988) Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc. Natl. Acad. Sci. USA 85, 8281–8285.
Ping, L.-H. and Lemon, S. M. (1992) Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J. Virol. 66, 2208–2216.
Porter, A. G. (1993) Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions. J. Viral. 67, 6917–6921.
Powdrill, T. F. and Johnston, J. M. (1991) Immunologic priming with recombinant hepatitis A virus proteins produced in e. coli. J. Virol. 65, 2686–2690.
Provost, P. J. and Hilleman, M. R. (1979) Propagation of human hepatitis A virus in cell culture in vitro. Proc. Soc. Exp. Biol. Med. 160, 213–221.
Purcell, R. H., Feinstone, S. M., Ticehurst, J. R., Daemer, R. J., and Baroudy, B. M. (1984) Hepatitis A virus, in Viral Hepatitis and Liver Disease ( Vyas, G. N., Dienstag, J. L., and Hoofnagle, J. H., eds.), Grune and Stratton, Orlando, pp. 9–22.
Rakela, J., Lange, S. M., Ludwig, J., and Baldus, W. P. (1985) Fulminant hepatitis: Mayo clinic experience with 34 cases. Mayo. Clin. Proc. 60, 289–292.
Reyes, R. R. and Pickering, L. K. (1992) Impact of child day care on infectious diseases in adults. Inf. Dis. Clin. N. Am. 6, 239–250.
Robertson, B. H., Jansen, R. W., Khanna, B., Totsuka, A., Nainan, O. V., Siegl, G., Widell, A., Margolis, H. S., Isomura, S., Ito, K., Ishizu, T., Moritsugu, Y., and Lemon, S. M. (1992) Genetic relatedness of hepatitis A virus strains recovered from different geographical regions../. Gen. Virol. 73, 1365–1377.
Robertson, B. H., Jia, X.-Y., Tian, H., Margolis, H. S., Summers, D. F., and Ehrenfeld, E. (1993) Antibody response to nonstructural proteins of hepatitis A virus following infection. J. Med. Virol. 40, 76–82.
Rosen, E., Stapleton, J. T., and McLinden, J. (1993) Synthesis of immunogenic hepatitis A virus particles by recombiant baculoviruses. Vaccine 11, 706–712.
Rosenblum, L. S., Villarino, M. E., Nainan, O. V., Melish, M. E., Hadler, S. C., Pinsky, P. P., Jarvis, W. R., Ott, C. E., and Margolis, H. S. (1991) Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J. Infect. Dis. 164, 476–482.
Ross, B. C. and Anderson, D. A. (1991) Characterization of hepatitis A virus capsid proteins with antisera raised to recombinant antigens. J. Virol. Meth. 32, 213–220.
Ross, B. C., Anderson, D. A., and Gust, I. D. (1991) Hepatitis A virus and hepatitis A infection. Adv. Virus Res. 39, 209–254.
Rueckert, R. R. (1996) Picornaviridae: the viruses and their replication, in Fields Virology ( Fields, B. N., Knipe, D. M., Howley, R. M., Chanuck, R. M., Melnick, J. L., Monath, T. R, Roizman, B., and Straus, S. E., eds.), Lippincott-Raven, Philadelphia, PA, pp. 609–654.
Rueckert, R. R. and Wimmer, E. (1984) Systematic nomenclature of picornavirus proteins. J. Virol. 50, 957–959.
Sagliocca, L., Mele, A., Gill, O. N., and Cappeta, G. (1988) A village outbreak of hepatitis A: acquaintance network and inapparent pre-school transmission compared. Eur. J. Epidemiol. 4, 470–472.
Schenzle, D., Kietz, K., and Frosner, G. G. (1979) Antibody against hepatitis A in seven European countries. II. Statistical analysis of cross-sectional surveys. Amer. J. Epidemiol. 110, 70–76.
Schoenbaum, S. C., Baker, O., and Jezek, Z. (1976) Common-source epidemic of hepatitis due to glazed and iced pastreis. Amer. J. Epidemiol. 104, 74–80.
Schultheiss, T., Kusov, Y. Y., and Gauss-Muller, V. (1994) Proteinase 3C of hepatitis A virus (HAV) cleaves the HAV polyprotein P2–P3 at all sites including VP1/2A and 2A/2B. Virology 198, 275–281.
Schultheiss, T., Sommergruber, W., Kusov, Y. Y., and Gauss-Muller, V. (1995) Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates. J. Virol. 69, 1727–1733.
Shapiro, C. N., McQuillan, G. M., Robertson, B., Hadler, S. C., and Margolis, H. S. (1990) Seroepidemiology of hepatitis A infection in the United States. 1990 Intern. Symp. Viral Hepatitis Liver Disease Abstr. 22, 44.
Shieh, Y.-S. C., Bark, R. S., Sobsey, M. D., Ticehurst, J., Miele, T. A., De Leon, R., and Walter, R. (1991) Detection of hepatitis A virus and other enteroviruses in water by ssRNA probes. J. Virol. Meth. 31, 119–136.
Siegl, G. and Frosner, G. G. (1978) Characterization and classification of virus particles associated with hepatitis A: I. size, density, and sedimentation. J. Virol. 26, 40–47.
Siegl, G., Frosner, G. G., Gauss-Muller, V., Tratschin, J. D., and Deinhardt, F. (1981) The physicochemical properties of infectious hepatitis A virion. J. Gen. Virol. 57, 331–341.
Siegl, G. and Lemon, S. M. (1990) Recent advances in hepatitis A vaccine development. Virus Res. 17, 75–92.
Siegl, G., Weitz, M., and Kronauer, G. (1984) Stability of hepatitis A virus. Intervirology 22, 218–226.
Sjogren, M. H., Purcell, R. H., McKee, K., Binn, L., Macarthy, P., Ticehurst, J., Feinstone, S., Caudill, J., See, A., Hoke, C., Bancroft, W., and D’Hondt, E. (1992) Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate. Vaccine 10, S 135 - S138.
Sjogren, M. H., Tanno, H., Fay, O., Sileoni, S., Cohen, B. D., Burke, D. S., and Feighny, R. J. (1987) Hepatitis A virus in stool during clinical relapse. Ann. Int. Med. 106, 221–226.
Skinhoj, P., Mikkelsen, F., and Hollinger, F. B. (1977) Hepatitis A in Greenland: importance of specific antibody testing in epidemiologic surveillance. Amer. J. Epidemiol. 105, 140–147.
Stapleton, J. T. (1992) Passive immunization against hepatitis A. Vaccine 10, S45 - S47.
Stapleton, J. T. (1995) Host immune response to hepatitis A virus. J. Infect. Dis. 171, s9–14.
Stapleton, J. T., Frederick, J., and Meyer, B. (1991) Hepatitis A virus attachment to cultured cell lines. J. Infect. Dis. 164, 1098–1103.
Stapleton, J. T., Jansen, R., and Lemon, S. M. (1985) Neutralizing antibody to Hepatitis A virus in immune serum gobulin and in the sera of human recipients of immune serum globulin. Gastroenterology 89, 637–642.
Stapleton, J. T. and Lemon, S. M. (1987) Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J. Virol. 61, 491–498.
Stapleton, J. T. and Lemon, S. M. (1994) Hepatitis A and hepatitis E, in Infectious Diseases, A Modern Treatise of Infectious Process ( Hoeprich, P. D., Jordan, M. C., and Ronald, A. R., eds.), J. B. Lippencott Company, Philadelphia, pp. 790–800.
Stapleton, J. T., Raina, V., Winokur, P. L., Walters, K., Klinzman, D., Rosen, E., and McLinden, J. H. (1993) Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles. J. Virol. 67, 1080–1085.
Stapleton, J. T., Rosen, E., and McLinden, J. (1991) Detection of hepatitis A virus capsid proteins in insect cells infected with recombinant baculoviruses encoding the entire hepatitis A virus open reading frame, in Viral Hepatitis and Liver Disease ( Hollinger, F. B., Lemon, S. M., and Margolis, H. S., eds.), Williams & Wilkins, Baltimore, MD, pp. 50–54.
Stewart, D. R., Morris, T. S., Purcell, R. H., and Emerson, S. U. (1997) Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus. J. Infect. Dis. 176, 593–601.
Summers, P. L., Dubois, D. R., Houston Cohen, W., MacArthy, P. 0., Binn, L. N., Sjogren, M. H., Snitbhan, R., Innis, B. L., and Eckels, K. H. (1993) Solid-phase antibody capture hemadsorption assay for detection of hepatitis A virus immunoglobulin M antibodies. J. Clin. Microbiol. 31, 1299–1302.
Szmuness, W., Dienstag, J. L., and Purcell, R. H. (1977) The prevalence of antibody to hepatitis A antigen in various parts of the world. Amer. J. Epidemiol. 106, 391–398.
Szmuness, W., Dienstag, J. L., Purcell, R. H., Harley, E. J., Stevens, C. E., and Wong, D. C. (1976) Distribution of antibody to hepatitis A antigen in urban adult populations. N. Engl. J. Med. 295, 755–759.
Tabor, E. (1984) Clinical presentation of hepatitis A, in Hepatitis A ( Gerety, R. J., ed.), Academic, London, pp. 47–53.
Tanno, H., Fay, O. H., Fojman, J. A., and Palazzi, J. (1988) Biphasic form of hepatitis A virus infection: a frequent variant in Argentina. Liver 7, 53–57.
Taylor, G. M., Goldin, R. D., Karayiannis, P., and Thomas, H. C. (1992), in situ hybridization studies in hepatitis A infection. Hepatology 16, 642–648.
Tedeschi, V., Purcell, R. H., and Emerson, S. U. (1993) Partial characterization of hepatitis A viruses from three intermediate passage levels of a series resulting in adaptation to growth in cell culture and attenuation of virulence. J. Med. Virol. 39, 16–22.
Ticehurst, J., Cohen, J. I., Feinstone, S. M., Purcell, R. H., Jansen, R. W., and Lemon, S. M. (1989) Replication of hepatitis A virus: new ideas from studies with cloned cDNA, in Molecular Aspects of Picornavirus Infection and Detection (Semler, B. L. and Ehrenfeld, E., eds.), Am. Soc. Microbiol. Washington, pp. 27–50.
Ticehurst, J. and Purcell, R. H. (1993) Hepatitis A virus and diagnostic techniques for hepatitis A, in Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections ( Schmidt, N. J. and Emmons, R., eds.), American Public Health Assoc., Washington.
Ticehurst, J. R., Feinstone, S. M., Chestnut, T., Tassopoulos, N. C., Popper, H., and Purcell, R. H. (1987) Detection of hepatitis A virus by extraction of viral RNA and molecular hybridization. J. Clin. Microbiol. 25, 1822–1829.
Tözün, N., Forbes, A., Anderson, M. G., and Murray-Lyon, I. M. (1991) Safety of alcohol after viral hepatitis. Lancet 337, 1079–1080.
Updike, W. S., Tesar, M., and Ehrenfeld, E. (1991) Detection of hepatitis A virus proteins in infected BS-C-1 cells. Virology 185, 411–418.
Vallbracht, A., Gabriel, P., Maier, K., Hartmann, F., and Flehmig, B. (1986) Cell-mediated cytotoxicity in hepatitis A virus infection. Hepatology 6, 1308–1314.
Vallbracht, A., Maier, K., Stierhof, Y. D., Wiedmann, K. H., Flehmig, B., and Fleischer, B. (1989) Liver-derived cytotoxic T cells in hepatitis A virus infection. J. Infect. Dis. 160, 209–217.
van den Anker, J. N., Sukhai, R. N., and Dumas, A. M. (1988) Relapsing hepatitis in a child associated with isolation of hepatitis A virus antigen from the liver. Eur. J. Ped. 147, 333.
Villarejos, V. M., Provost, P. J., and Ittensohn, O. L. (1976) Seroepidemiologic investigations of human hepatitis caused by A, B., and a possible third agent. Proc. Soc. Exp. Biol. Med. 152, 524–528.
Weitz, M., Baroudy, B. M., Maloy, W. L., Ticehurst, J. R., and Purcell, R. H. (1986) Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs. J. Virol. 60, 124–130.
Weitz, M. and Siegl, G. (1993) Hepatitis A virus: Structural and molecular virology, in Viral Hepatitis—Scientific Basis and Clinical Management ( Zuckerman, A. J. and Thomas, H. C., eds.), Churchill Livingstone, Edinburgh, U.K., pp. 21–34.
Widell, A. (1988) Hepatitis A Virus Virological Studies, doctoral dissertation, University of Lund, Sweden 1, 3–12.
Wiedermann, G., Ambrosch, F., Kollaritsch, H., Hofmann, H., Kunz, C., D’Hondt, E., Delem, A., André, F. E., Safary, A., and Stéphenne, J. (1990) Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine 8, 581–584.
Winokur, P. L., McLinden, J. H., and Stapleton, J. T. (1991) The hepatitis A virus polyprotein expressed by a recombinant vaccinia virus undergoes proteolytic processing and assembly into virus-like particles. J. Virol. 65, 5029–5036.
Winokur, P. L. and Stapleton, J. T. (1992) Immunoglobulin prophylaxis for hepatitis A. Clin. Infect. Dis. 14, 580–586.
Wunschmann, S., Vallbracht, A., Flehmig, B., Winokur, P., Klinzman, D., and Stapleton, J. T. (1997) Cytolytic T lymphocyte epitopes are present on hepatitis A virus structural proteins, in Viral Hepatitis and Liver Disease (Rizzeto, M., ed.), in press.
Xu, Z.-Y., Li, Z.-H., Wang, J.-X., Xiao, Z.-P., and Dong, D.-X. (1992) Ecology and prevention of a shellfish-associated hepatitis A epidemic in Shanghai, China. Vaccine 10 (Suppl. 1), S67 - S68.
Zachoval, R., Kroener, M., Brommer, M., and Deinhardt, E (1990) Serology and interferon production during the early phase of acute hepatitis A. J. Infect. Dis. 161, 353–354.
Zajac, A. J., Amphlett, E. M., Rowlands, D. J., and Sangar, D. V. (1991) Parameters influencing the attachment of hepatitis A virus to a variety of continuous cell lines. J. Gen. Virol. 72, 1667–1675.
Zuckerman, A. J. (1983) The history of viral hepatitis from antiquity to the present, in Viral Hepatitis: Laboratory and Clinical Science ( Deinhardt, F. and Deinhardt, J., eds.), Marcel Dekker, New York, pp. 3–32.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stapleton, J.T. (1999). Hepatitis A Virus. In: Specter, S. (eds) Viral Hepatitis. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-702-4_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-702-4_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-033-5
Online ISBN: 978-1-59259-702-4
eBook Packages: Springer Book Archive